A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis
Clinical trial NCT07432854 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07432854
- Sponsor
- Dermavon Holdings Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-03
- Primary completion
- 2028-02-29
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.